UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000030717
Receipt number R000035070
Scientific Title The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer.
Date of disclosure of the study information 2018/04/01
Last modified on 2019/10/04 17:00:36

No. Disposal Last modified on Item of update
1 Insert 2018/01/07 12:58:03
2 Update 2018/07/12 22:11:14 Anticipated trial start date
3 Update 2019/10/04 17:00:36 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date